FORT LEE, N.J., March 31 /PRNewswire-FirstCall/ -- Alpharma Inc. today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.045 per common share. The dividend is payable April 28, 2006 to all shareholders on record as of April 14, 2006.
Alpharma Inc. is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world’s leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.
Alpharma press releases are also available at our website: http://www.alpharma.com.
Alpharma Inc.
CONTACT: Kathleen Makrakis, VP, Investor Relations of Alpharma Inc.,+1-201-228-5085, kathleen.makrakis@alpharma.com
Web site: http://www.alpharma.com/
